Everything tagged "medical diagnostics and research" across research, earnings, and macro.
7 articles
Thermo Fisher Scientific Inc. (TMO) rises after a broad Q2 beat, margin expansion, and a full-year guidance raise. This deep-dive examines the company’s share-gain narrative, end-market strength, five-quarter EPS beat streak, and what the stronger organic growth outlook could mean for the stock.
Thermo Fisher Scientific Inc. (TMO) climbs 10.1% after reporting earnings beats, lifting investor sentiment as the company tops expectations and signals stronger-than-expected performance.
Revvity, Inc. (RVTY) rises after a clean Q1 earnings beat, but the real story is in the details: stronger-than-expected margins, steady organic growth, and a guidance reset tied to a strategic China exit rather than core business weakness. Here’s what the numbers and outlook really mean.
Revvity, Inc. (RVTY) rises 7.0% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook signals.
Twist Bioscience Corporation (TWST) drops despite revenue growth and raised guidance, as a wider-than-expected EPS loss overshadowed strong segment momentum, margin improvement, and continued sequential sales gains. This deep-dive breaks down the earnings miss, operating trends, and why investors focused on profitability over the top-line beat.
Twist Bioscience Corporation (TWST) drops 5.5% after reporting earnings misses, as investors react to weaker-than-expected results and reassess the stock's near-term outlook.
Thermo Fisher Scientific Inc. (TMO) slips 2.0% after reporting earnings that met expectations, as investors react to the latest quarterly results.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator